Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

(Radiology) The Farapulse pulsed field ablation system got the FDA's expanded approval for treating drug-refractory, symptomatic persistent atrial fibrillation, Boston Scientific said. The location of ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...